BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10229953)

  • 1. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression and Parkinson disease].
    Errea JM; Ara JR
    Rev Neurol; 1999 Apr 1-15; 28(7):694-8. PubMed ID: 10363296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
    Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
    Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.
    Gagnon JF; Vendette M; Postuma RB; Desjardins C; Massicotte-Marquez J; Panisset M; Montplaisir J
    Ann Neurol; 2009 Jul; 66(1):39-47. PubMed ID: 19670440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative clinical study of patients with Parkinson disease and essential tremor].
    Errea-Abad JM; Ara-Callizo JR
    Rev Neurol; 1998 Jul; 27(155):39-43. PubMed ID: 9674022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in Nigerians with Parkinson's disease.
    Akinyemi RO; Okubadejo NN; Akinyemi JO; Owolabi MO; Owolabi LF; Ogunniyi A
    Mov Disord; 2008 Jul; 23(10):1378-83. PubMed ID: 18546341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.